Bank of New York Mellon Corp trimmed its holdings in Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 154,312 shares of the specialty chemicals company's stock after selling 17,567 shares during the period. Bank of New York Mellon Corp owned 0.74% of Hawkins worth $18,929,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Vaughan Nelson Investment Management L.P. lifted its stake in shares of Hawkins by 487.7% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 254,837 shares of the specialty chemicals company's stock valued at $31,260,000 after purchasing an additional 211,472 shares in the last quarter. FMR LLC lifted its stake in shares of Hawkins by 20.9% in the 3rd quarter. FMR LLC now owns 256,245 shares of the specialty chemicals company's stock valued at $32,663,000 after purchasing an additional 44,351 shares in the last quarter. State Street Corp lifted its position in Hawkins by 5.4% during the 3rd quarter. State Street Corp now owns 755,995 shares of the specialty chemicals company's stock worth $96,367,000 after acquiring an additional 38,877 shares in the last quarter. Jane Street Group LLC lifted its position in Hawkins by 127.3% during the 3rd quarter. Jane Street Group LLC now owns 47,432 shares of the specialty chemicals company's stock worth $6,046,000 after acquiring an additional 26,568 shares in the last quarter. Finally, De Lisle Partners LLP lifted its position in Hawkins by 39.8% during the 3rd quarter. De Lisle Partners LLP now owns 92,024 shares of the specialty chemicals company's stock worth $11,745,000 after acquiring an additional 26,201 shares in the last quarter. 69.71% of the stock is owned by institutional investors and hedge funds.
Hawkins Stock Up 4.8 %
Hawkins stock traded up $4.92 during midday trading on Friday, hitting $108.00. 117,738 shares of the company were exchanged, compared to its average volume of 143,311. The company's fifty day moving average price is $111.06 and its 200-day moving average price is $119.97. The company has a market cap of $2.26 billion, a PE ratio of 27.55, a price-to-earnings-growth ratio of 3.80 and a beta of 0.77. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.50 and a quick ratio of 1.53. Hawkins, Inc. has a fifty-two week low of $71.20 and a fifty-two week high of $139.55.
Hawkins (NASDAQ:HWKN - Get Free Report) last released its quarterly earnings results on Wednesday, January 29th. The specialty chemicals company reported $0.72 EPS for the quarter, missing the consensus estimate of $0.77 by ($0.05). Hawkins had a return on equity of 18.95% and a net margin of 8.60%. On average, research analysts predict that Hawkins, Inc. will post 4 EPS for the current fiscal year.
Hawkins Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $0.72 annualized dividend and a yield of 0.67%. Hawkins's dividend payout ratio is presently 18.37%.
Wall Street Analysts Forecast Growth
Separately, BWS Financial reissued a "neutral" rating and set a $122.00 price target on shares of Hawkins in a research report on Friday, January 31st.
Check Out Our Latest Research Report on Hawkins
Hawkins Profile
(
Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Read More

Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.